Citadel Advisors »

AgomAb Therapeutics NV shares owned by Citadel Advisors

Quarter-by-quarter ownership of AgomAb Therapeutics NV shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in AgomAb Therapeutics NV

Tip: Access up to 7 years of quarterly data

All positions including AgomAb Therapeutics NV held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in AgomAb Therapeutics NV by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $367k 35k 10.49

More positions owned by Citadel Advisors

State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
NVIDIA Corporation Call Option (NVDA)
Tesla Motors Call Option (TSLA)
Spdr Gold Tr Gold Shs Call Option (GLD)
Apple Call Option (AAPL)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Call Option (MSFT)
Amazon Call Option (AMZN)
Micron Technology Call Option (MU)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Netflix Call Option (NFLX)
Broadcom Call Option (AVGO)
Alphabet Cap Stk Cl C Call Option (GOOG)

View all positions for Citadel Advisors

Top funds holding AgomAb Therapeutics NV

Sanofi
Cormorant Asset Management
TCG Crossover Management
Federated Investors
Casdin Capital
Andera Partners
FMR
Nantahala Capital Management
Standard Life Aberdeen
Perceptive Advisors
Samsara BioCapital
LMR Partners
Seven Grand Managers
Redmile Group
Millennium Management

View all funds holding AgomAb Therapeutics NV